SCHEMBL890685

SCHEMBL890685

CCCCCCCCC[CH]I

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
THRB P10828 1/20 0.50
EP300 Q09472 1/20 0.46
FAAH O00519 2/20 0.46
TRPV1 Q8NER1 1/20 0.46
DNM1 Q05193 3/20 0.45
GMNN O75496 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX15 P16050 1/20 0.44
APEX1 P27695 1/20 0.44
CYP2C19 P33261 1/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL809946 1.00
SCHEMBL6622271 1.00 TSHR (0.52) TSHRTHRBEP300FAAHTRPV1
SCHEMBL17510806 1.00 TSHR (0.52) TSHRTHRBEP300FAAHTRPV1
SCHEMBL7871012 1.00 TSHR (0.52) TSHRTHRBEP300FAAHTRPV1
SCHEMBL958325 1.00
SCHEMBL11359275 1.00 TSHR (0.52) TSHRTHRBEP300FAAHTRPV1
SCHEMBL497990 0.97
SCHEMBL1567812 0.87
SCHEMBL7555214 0.78 TSHR (0.55) TSHRTHRBEP300FAAHTRPV1
SCHEMBL3235111 0.78 TSHR (0.55) TSHRTHRBEP300FAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112206223-B System for transdermal delivery of active substances LTS勒曼治疗系统股份公司 2024-07-02 CN disclosed
US-11860535-B2 Imprint lithography stamp method of making and using the same KONINKLIJKE PHILIPS N.V. (NL) 2024-01-02 US disclosed
CN-115315452-A Propylene polymers obtained using transition metal bis (phenolate) catalyst complexes and homogeneous processes for producing the same 埃克森美孚化学专利公司 2022-11-08 CN disclosed
CN-112206223-A System for transdermal delivery of active substances LTS勒曼治疗系统股份公司 2021-01-12 CN disclosed
US-10696640-B2 Fluoroalkylating agent KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2020-06-30 US disclosed
US-20190233380-A1 FLUOROALKYLATING AGENT KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2019-08-01 US disclosed
US-20180265538-A1 THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2018-09-20 US disclosed
US-20140256811-A1 EFFICIENT STABILIZER IN CONTROLLING SELF ACCELERATED DECOMPOSITION TEMPERATURE OF PEROXYCARBOXYLIC ACID COMPOSITIONS WITH MINERAL ACIDS ECOLAB USA INC. (US) 2014-09-11 US disclosed
US-8765838-B2 Non-aqueous ink composition for inkjet printing RISO KAGAKU CORPORATION (JP) 2014-07-01 US disclosed
US-8592610-B2 Spiroheterocyclic tetronic acid derivatives BAYER CROPSCIENCE AG (DE) 2013-11-26 US disclosed
EP-0719839-B1 Phthalocyanine compounds and optical recording media comprising them MITSUI CHEMICALS INC (JP) 2001-07-25 EP disclosed
EP-0700916-B1 CEPHEM COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ANTIBACTERIAL CONTAINING THE COMPOUND OTSUKA KAGAKU KK (JP) 2001-06-20 EP disclosed
EP-0910383-A1 THE USE OF GROWTH FACTOR MODULATING COMPOUNDS PERSTORP AB (SE) 1999-04-28 EP disclosed
WO-1997049408-A1 THE USE OF GROWTH FACTOR MODULATING COMPOUNDS PERSTORP AB (SE) 1997-12-31 WO disclosed
US-5698544-A ANTIBOIOTIC AGAINST METHICILLIN RESISTANCE STAPHYLOCOCCUS AUREUS OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-12-16 US disclosed
US-5693396-A NEAR INFRARED LIGHT ABSORBERS MITSUI TOATSU CHEMICALS, INC. (JP) 1997-12-02 US disclosed
US-5635500-A EFFECTIVE IN TREATING INFECTIOUS DISEASES ASSOCIATED WITH METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-06-03 US disclosed
EP-0719839-A2 Phthalocyanine compounds and optical recording media comprising them MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-07-03 EP disclosed
EP-0700916-A1 CEPHEM COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ANTIBACTERIAL CONTAINING THE COMPOUND OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1996-03-13 EP disclosed
EP-0630899-A1 CEPHEM COMPOUND, PROCESS FOR PRODUCING THE SAME, AND MEDICINE CONTAINING THE SAME OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1994-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10696640-B2 Fluoroalkylating agent AFF1, AFF4, AFF2 TSHR 270/4885THRB 3128/4885EP300 3299/4885
US-20190233380-A1 FLUOROALKYLATING AGENT AFF1, AFF4, AFF2 TSHR 270/4885THRB 3128/4885EP300 3299/4885
US-20180265538-A1 THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES TST, APEX1, TMT1A TSHR 1941/4885THRB 1486/4885EP300 4273/4885
US-20140256811-A1 EFFICIENT STABILIZER IN CONTROLLING SELF ACCELERATED DECOMPOSITION TEMPERATURE OF PEROXYCARBOXYLIC ACID COMPOSITIONS WITH MINERAL ACIDS HAO2, PRDX2, SLC25A21 TSHR 4150/4885THRB 4566/4885EP300 2489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.